Inflammatix has a total of 34 patents globally, out of which 5 have been granted. Of these 34 patents, more than 79% patents are active. United States of America is where Inflammatix has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Inflammatix.
Inflammatix was founded in the year 2016. The company’s line of business includes providing management consulting services.
Do read about some of the most popular patents of Inflammatix which have been covered by us in this article and also you can find Inflammatix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Inflammatix patent portfolio.
How many patents does the founder and the CEO of Inflammatix have?
The founder Jonathan Romanowsky has 0 patent and Purvesh Khatri has 7 patents and CEO Tim Sweeney has 7 patents.
How many patents does Inflammatix have?
Inflammatix has a total of 34 patents globally. These patents belong to 9 unique patent families. Out of 34 patents, 27 patents are active.
How Many Patents did Inflammatix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Inflammatix Applications Filed | Inflammatix Patents Granted |
| 2022 | 6 | – |
| 2021 | 6 | 1 |
| 2020 | 9 | – |
| 2019 | 7 | – |
| 2018 | – | 1 |
| 2013 | – | 1 |
| 2011 | – | 2 |
| 2008 | 1 | – |
| 2007 | 5 | – |
How many Inflammatix patents are Alive/Dead?
How Many Patents did Inflammatix File in Different Countries?
Countries in which Inflammatix Filed Patents
| Country | Patents |
| United States Of America | 10 |
| Europe | 4 |
| Canada | 3 |
| Australia | 3 |
| Japan | 2 |
| United Kingdom | 1 |
| Israel | 1 |
| India | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Inflammatix Patents Located?
The Research Centre for all the Inflammatix patents is the United States of America.
What Percentage of Inflammatix US Patent Applications were Granted?
Inflammatix (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 66.67%.
Below are the key stats of Inflammatix patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Inflammatix?
| Law Firm | Total Applications | Success Rate |
| Schox | 7 | 100.00% |
| Constellation Law Group | 2 | 0.00% |
List of Inflammatix Patents
| Inflammatix Patents | Title |
| US11104946B2 | Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome |
| US10001496B2 | Systems For Allergen Detection |
| US8617903B2 | Methods For Allergen Detection |
| US8068991B2 | Systems And Methods For Transmitting Pathogen Related Information And Responding |
| US20220399116A1 | Systems And Methods For Assessing A Bacterial Or Viral Status Of A Sample |
| US20210214779A1 | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
| US20210086172A1 | Fluidic Methods |
| US20200303078A1 | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| EP4143343A1 | Determining Mortality Risk Of Subjects With Viral Infections |
| EP3942556A4 | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| EP3853376A4 | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
| WO2023014598A3 | Isothermal Amplification-Based Diagnosis And Treatment Of Acute Infection |
| WO2023034111A1 | A Baseline Gene Expression-Based Prognostic For Anti-Tnf Alpha Therapy Response In Patients With Inflammatory Bowel Disease |
| WO2022235765A3 | Systems And Methods For Assessing A Bacterial Or Viral Status Of A Sample |
| WO2022240942A1 | Methods Of Diagnosis Of Respiratory Viral Infections |
| GB2460196B | Fluidic Methods |
| AU2021264555A1 | Determining Mortality Risk Of Subjects With Viral Infections |
| AU2020244763A1 | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| AU2019345037A1 | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
| CA3177170A1 | Determining Mortality Risk Of Subjects With Viral Infections |
| CA3133639A1 | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| CA3117201A1 | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
| JP2023525489A | Determining Mortality Risk In Subjects With Viral Infections |
| JP2022500060A | Assessment Of Host Rna Using Isothermal Amplification And Relative Abundance |
| HK40057256A | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
| IL286293A | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| IN202147045891A | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| US20080245740A1 | Fluidic Methods |
| US20080241910A1 | Devices For Pathogen Detection |
| EP3959338A1 | Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome |
| WO2021222537A1 | Determining Mortality Risk Of Subjects With Viral Infections |
| WO2020219465A1 | Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome |
| WO2020198068A1 | Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets |
| WO2020061217A1 | Assessing Host Rna Using Isothermal Amplification And Relative Abundance |
What are Inflammatix key innovation segments?
What Technologies are Covered by Inflammatix?
The chart below distributes patents filed by Inflammatix